SVP, Development Michael David Smith sold $201K of KalVista Pharmaceuticals, Inc.

Sold$201,221

$26.83Price

7,500Shares

−100%Stake

What KALV did after the filing

Prices for KALV after this filing aren't in yet.

Traded Tue, Jun 1. Filed Thu, Jun 3, 2:28 PM ET, during the session. Not investment advice.